Beta Bionics, Inc. Common Stock BBNX

$22.18 +15.34% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-09-17 View →
424B5 424B5 2026-09-17 View →
424B5 424B5 2026-09-16 View →
8-K 8-K 2026-09-15 View →
4 Insider transaction 2026-09-15 View →
4 Insider transaction 2026-09-10 View →
4 Insider transaction 2026-09-04 View →
4 Insider transaction 2026-09-03 View →
4 Insider transaction 2026-09-03 View →
4 Insider transaction 2026-09-03 View →
4 Insider transaction 2026-09-03 View →
4 Insider transaction 2026-09-03 View →
10-Q 10-Q 2026-07-29 View →
8-K FORM 8-K 2026-07-29 View →
4 Insider transaction 2026-06-30 View →
4 Insider transaction 2026-06-25 View →
4 Insider transaction 2026-06-25 View →
4 Insider transaction 2026-06-05 View →
4 Insider transaction 2026-06-05 View →
4 Insider transaction 2026-06-03 View →
4 Insider transaction 2026-06-03 View →
4 Insider transaction 2026-06-03 View →
4 Insider transaction 2026-06-03 View →
4 Insider transaction 2026-06-03 View →
4 Insider transaction 2026-05-26 View →
4 Insider transaction 2026-05-26 View →
4 Insider transaction 2026-05-26 View →
4 Insider transaction 2026-05-26 View →
4 Insider transaction 2026-05-26 View →
4 Insider transaction 2026-05-26 View →
8-K FORM 8-K 2026-05-22 View →
8-K FORM 8-K 2026-05-21 View →
10-Q 10-Q 2026-04-21 View →
8-K FORM 8-K 2026-04-21 View →
DEF 14A DEF 14A 2026-04-10 View →
4 Insider transaction 2026-03-16 View →
4 Insider transaction 2026-03-16 View →
4 Insider transaction 2026-03-05 View →
4 Insider transaction 2026-03-03 View →
4 Insider transaction 2026-03-03 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$22.18
Market Cap
$997.87 million
52-Week Range
$8.80 $32.71
Average Volume
1.27 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.